RADICAVA ORS

Drug MITSUBISHI TANABE PHARMA AMERICA, INC.
Total Payments
$72,338
Transactions
74
Doctors
13
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $65,970 67 12
2023 $6,368 7 4

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $38,848 26 53.7%
Space rental or facility fees (teaching hospital only) $13,000 4 18.0%
Travel and Lodging $10,114 27 14.0%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,410 3 13.0%
Food and Beverage $966.49 14 1.3%

Top Doctors Receiving Payments for RADICAVA ORS

Doctor Specialty Location Total Records
, M.D Neurology Lincoln, NE $13,315 18
Unknown Salt Lae City, UT $13,000 4
, MD Neurology Los Angeles, CA $9,637 7
, MD Internal Medicine Charlotte, NC $6,391 7
, MD Neurology Philadelphia, PA $6,317 7
, MD, PHD Neuromuscular Medicine Chicago, IL $6,143 5
, M.D Anatomic Pathology & Clinical Pathology San Francisco, CA $5,987 7
, MD Neurology Hamilton, NY $5,980 8
, MD Neurology Seattle, WA $1,697 5
, M.D Neurology Westerville, OH $1,500 2
, M.D Neurology Phoenix, AZ $1,000 1
, MD Neurology Chattanooga, TN $800.00 1
, MD Neurology Gainesville, FL $550.00 1
, M.D Neurological Surgery Mobile, AL $20.88 1

About RADICAVA ORS

RADICAVA ORS is a drug associated with $72,338 in payments to 13 healthcare providers, recorded across 74 transactions in the CMS Open Payments database. The primary manufacturer is MITSUBISHI TANABE PHARMA AMERICA, INC..

Payment data is available from 2023 to 2024. In 2024, $65,970 was paid across 67 transactions to 12 doctors.

The most common payment nature for RADICAVA ORS is "Consulting Fee" ($38,848, 53.7% of total).